UCL news

Comment: I’ve treated 20-year-olds with dementia. These are the early warning signs
Comment: I’ve treated 20-year-olds with dementia. These are the early warning signs

Comment: I’ve treated 20-year-olds with dementia. These are the early warning signs

These key warning signs for young-onset dementia can easily be ignored or misdiagnosed, writes Professor Nick Fox (UCL Queen Square Institute of Neurology) in an article for The Telegraph.

27 Jan 2026

Scientists test whether finger prick blood test could help diagnose Alzheimer’s
Scientists test whether finger prick blood test could help diagnose Alzheimer’s

Scientists test whether finger prick blood test could help diagnose Alzheimer’s

A major international research project involving UCL is underway to test whether a finger prick-style blood test could be used to help diagnose Alzheimer’s disease, even before symptoms begin.

19 Jan 2026

AI analysis reveals two distinct types of multiple sclerosis
AI analysis reveals two distinct types of multiple sclerosis

AI analysis reveals two distinct types of multiple sclerosis

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been able to identify two biologically distinct types of multiple sclerosis (MS), in research led by UCL and Queen Square Analytics, a UCL spin out company.

05 Jan 2026

Institute news

Professor Giampetro Schiavo wins 2026 International Neurotoxin Association (INA) award
Professor Giampetro Schiavo wins 2026 International Neurotoxin Association (INA) award

Professor Giampetro Schiavo wins 2026 International Neurotoxin Association (INA) award

Professor Schiavo (UCL Queen Square Institute of Neurology) received the 2026 INA Basic Science Lifetime Achievement Award from the President at the bi-annual congress of the society.

26 Jan 2026

New Vacancy - Bioinformatician
New Vacancy - Bioinformatician

New Vacancy - Bioinformatician

Work alongside clinical experts, bioinformaticians, and basic scientific researchers at a world-leading institution to make a tangible difference to the NMD rare disease community.

23 Jan 2026

Multiple sclerosis treatments can be just as effective for older adults
Multiple sclerosis treatments can be just as effective for older adults

Multiple sclerosis treatments can be just as effective for older adults

Older adults with a common type of multiple sclerosis benefit from disease-modifying treatments just as much as younger patients, finds a UCL-led study.

20 Jan 2026